AJR ARRS Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heilbrun, M. E.
Right arrow Articles by Clark, P. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heilbrun, M. E.
Right arrow Articles by Clark, P. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
DOI:10.2214/AJR.06.0389
AJR 2007; 188:1500-1505
© American Roentgen Ray Society


Clinical Observations

CT-Guided Biopsy for the Diagnosis of Renal Tumors Before Treatment with Percutaneous Ablation

Marta E. Heilbrun1,2, Ronald J. Zagoria1, A. Julian Garvin3, M. Craig Hall4, Kyle Krehbiel1, Andrew Southwick5 and Peter E. Clark4

1 Department of Radiology, Wake Forest University School of Medicine, Winston-Salem, NC.
2 Present address: Department of Radiology, University of Utah Health Sciences Center, 30 North 1900 East #1A071, Salt Lake City, UT 84132-2140.
3 Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, NC.
4 Department of Urology, Wake Forest University School of Medicine, Winston-Salem, NC.
5 Division of Urology, University of Utah Hospital and Clinics, Salt Lake City, UT.

OBJECTIVE. Percutaneous thermal ablation is an emerging technique in the management of renal cell carcinoma (RCC), with greatest efficacy in tumors ≤ 3 cm. The purpose of this retrospective study was to evaluate the role and utility of pretreatment CT-guided biopsy in patients referred for percutaneous thermal ablation of renal tumors.

CONCLUSION. Less than 5% of samples in our study were benign, and 11.8% were nondiagnostic. Biopsy in smaller lesions was less accurate; therefore biopsy is less useful for these renal lesions. Because fine-needle aspiration (FNA) has higher sensitivity than core biopsy, an appropriate algorithm may be to begin with FNA and reserve core biopsy for cases in which an onsite cytotechnologist is unavailable or deems the sample of inadequate cellularity.

Keywords: ablation • biopsy • CT • oncology • percutaneous ablation • renal disease


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
R. J. Stanley
Our Practice of Radiology: Reflections on its Growth and Stature
Am. J. Roentgenol., June 1, 2007; 188(6): 1439 - 1439.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Roentgen Ray Society.